- rejection at 272 against a weakening high growth stock backdrop + china crackdown on tech monopoly
- downside to 228
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
